Importantly, in transplant recipients treated with unselected donor lymphocytes for the relapse of AML or myeloma, expansion of WT-1 specific T-cells closely correlates with the eradication of tumour cells and the achievement of complete remission [57]. This evidence concerns the gene WT1 and plasma cell myeloma.